Page last updated: 2024-08-25

4-aminopyrazolo(3,4-d)pyrimidine and Dyslipidemia

4-aminopyrazolo(3,4-d)pyrimidine has been researched along with Dyslipidemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeBrota, DJ; Green, C; Leohr, JK; Luffer-Atlas, D; Luo, MJ; Mabry, TE; Suico, JG1
Ascoli, M1

Trials

1 trial(s) available for 4-aminopyrazolo(3,4-d)pyrimidine and Dyslipidemia

ArticleYear
Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase-1.
    Journal of clinical pharmacology, 2018, Volume: 58, Issue:4

    Topics: Adenine; Adult; Aged; Alanine Transaminase; Cholesterol, LDL; Cross-Over Studies; Dyslipidemias; Female; Humans; Male; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ribosomal Protein S6 Kinases, 70-kDa; Single-Blind Method; Young Adult

2018

Other Studies

1 other study(ies) available for 4-aminopyrazolo(3,4-d)pyrimidine and Dyslipidemia

ArticleYear
Effects of hypocholesterolemia and chronic hormonal stimulation on sterol and steroid metabolism in a Leydig cell tumor.
    Journal of lipid research, 1981, Volume: 22, Issue:8

    Topics: Adenine; Animals; Cholesterol; Chorionic Gonadotropin; Dyslipidemias; Kinetics; Leydig Cell Tumor; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Steroids; Sterols; Testicular Neoplasms

1981